Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Chang Juan Tao"'
Autor:
Ling Zhou, Jia Chen, Wei Shen, Zheng-Lu Chen, Shuang Huang, Chang-Juan Tao, Ming Chen, Zhong-Hua Yu, Yuan-Yuan Chen
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-8 (2020)
Abstract Background We investigated the risk factors of radiation-induced thyroid dysfunction, then combined the clinical factors and optimum thyroid dosimetric parameters to predict the incidence rate of hypothyroidism (HT) and to guide individualiz
Externí odkaz:
https://doaj.org/article/34c1c302adda425c9cc881afbe9123b3
Publikováno v:
Neoplasma. 70:229-239
Publikováno v:
Translational Cancer Research
Background Platinum-based chemotherapy is the standard first-line treatment for recurrent/metastatic nasopharyngeal carcinoma (NPC); however, there is no standard regimen for those who failed first-line treatment. This study aimed to evaluate the eff
Autor:
Ling Zhou, Jia Chen, Chang-Juan Tao, Qing-Feng Zhao, Yu-Ming Chen, Xiao-Zhong Chen, Ming Chen, Zhong-Hua Yu, Yuan-Yuan Chen
Publikováno v:
Journal of Oncology, Vol 2022 (2022)
Background. It is controversial and unclear how N-stage would increase the risk of incidence of hypothyroidism (HT) for patients with nasopharyngeal carcinoma (NPC) after radiotherapy. Our study aimed to explore the correlation between cervical lymph
Autor:
Wei Lin Chen, Joseph Wee, Yueming Jin, Chuan Miao Xie, Guan Qun Zhou, Hao Chen, Jun Ma, Ying Sun, Ling Long Tang, Feng Liu, Li Lin, Ning Jiang, Melvin L.K. Chua, Pheng-Ann Heng, Shao Min Huang, Bao An Su, Chang Juan Tao, Yi Qiang Tang, Jun Yun Li, Qi Dou
Publikováno v:
Radiology. 291:677-686
Background Nasopharyngeal carcinoma (NPC) may be cured with radiation therapy. Tumor proximity to critical structures demands accuracy in tumor delineation to avoid toxicities from radiation therapy; however, tumor target contouring for head and neck
Autor:
Chang-Juan Tao, Li Lin, Guan-Qun Zhou, Ling-Long Tang, Lei Chen, Yan-Ping Mao, Mu-Sheng Zeng, Tie-Bang Kang, Wei-Hua Jia, Jian-Yong Shao, Hai-Qiang Mai, Ai-Hua Lin, Jun Ma, Ying Sun
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e110765 (2014)
BACKGROUND:We aimed to compare the long-term survival outcomes and acute toxicity of cisplatin administered weekly versus every three weeks concurrently with intensity-modulated radiotherapy (IMRT) in patients with nasopharyngeal carcinoma (NPC). MET
Externí odkaz:
https://doaj.org/article/6ca87f864c1b4b1d88531267bdfe2aaf
Autor:
Wei Shen, Yuanyuan Chen, Chaonan Zhu, Shuang Huang, Jiang Zhang, Jia Chen, Chang-Juan Tao, Zhonghua Yu, Ling Zhou, Ming Chen
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2020 (2020)
BioMed Research International, Vol 2020 (2020)
Background. This study explored the relationship between thyroid-associated antibodies, immune cells, and hypothyroidism to establish a predictive model for the incidence of hypothyroidism in patients with nasopharyngeal carcinoma (NPC) after radioth
Autor:
Yuan Yuan Chen, Wei Shen, Ling Zhou, Ming Chen, Zheng Lu Chen, Jia Chen, Shuang Huang, Chang Juan Tao, Zhong Hua Yu
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 15, Iss 1, Pp 1-8 (2020)
Radiation Oncology, Vol 15, Iss 1, Pp 1-8 (2020)
Background We investigated the risk factors of radiation-induced thyroid dysfunction, then combined the clinical factors and optimum thyroid dosimetric parameters to predict the incidence rate of hypothyroidism (HT) and to guide individualized treatm
Autor:
Chang-Juan Tao, Ming Chen, Kainan Shao, Yiwei Yang, Rui Huang, Dimitris N. Metaxas, Jie Zhang, Hongsheng Li, Yunhe Gao, Yuanyuan Chen
Publikováno v:
Medical image analysis. 67
Radiotherapy is a treatment where radiation is used to eliminate cancer cells. The delineation of organs-at-risk (OARs) is a vital step in radiotherapy treatment planning to avoid damage to healthy organs. For nasopharyngeal cancer, more than 20 OARs
Autor:
Shuzhen Lai, Chang-Juan Tao, Peijing Li, Xiaohui Liu, Zhigang Liu, Fagui Jiang, Lei Wang, Guihong Liu, Jing Huang, Chaoming Li, Yuan yuan Yuan Chen, Fangxiao Lu, Guoping Shen, Tieming Xie, Yiqiang Tang
Publikováno v:
Journal of Clinical Oncology. 39:2039-2039
2039 Background: STUPP regimen is now the standard treatment for newly diagnosed GBM, while the effectiveness is limited. This study assessed the efficacy and safety of anlotinib, a multitarget tyrosine kinase inhibitor, combined with the STUPP regim